Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for clinical trials
Clinical trials and tribulations Clinical trials and tribulations Reviewed by Dr Claire Gregg on Tuesday, January 13, 2026 Rating: 5
Plausibility as a moving target: Phase III clinical trial results sink second medical use patent (T 0816/22) Plausibility as a moving target: Phase III clinical trial results sink second medical use patent (T 0816/22) Reviewed by Dr Rose Hughes on Wednesday, January 22, 2025 Rating: 5
Confidentiality restrictions around clinical trials and prior public use (T 0670/20) Confidentiality restrictions around clinical trials and prior public use (T 0670/20) Reviewed by Dr Rose Hughes on Tuesday, January 31, 2023 Rating: 5
Lost in translation: Are animal models predictive of a treatment effect? Lost in translation: Are animal models predictive of a treatment effect? Reviewed by Dr Rose Hughes on Friday, January 18, 2019 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.